We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+12.56%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.7B
AUM Growth
+$4.94B
(+10%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
26.8%
Holding
1,539
New
66
Increased
528
Reduced
500
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$157M |
| 2 |
Verizon
VZ
|
+$140M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
KLA
KLAC
|
+$115M |
| 5 |
Dell
DELL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XRTX
XORTX Therapeutics
XRTX
|
+$161M |
| 2 |
L3Harris
LHX
|
+$104M |
| 3 |
Voya Financial
VOYA
|
+$99.6M |
| 4 |
BCE
BCE
|
+$88.6M |
| 5 |
NVIDIA
NVDA
|
+$87.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.6% |
| 2 | Healthcare | 16.46% |
| 3 | Financials | 10.3% |
| 4 | Industrials | 9.81% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Paycom
PAYC
$10.1B
| $1.77M | ﹤0.01% |
9,080
-1,402
| -13% | -$268K |
|
777
Tyler Technologies
TYL
$13.5B
| $1.77M | ﹤0.01% |
4,229
-2,690
| -39% | -$1.15M |
|
|
CTLT
778
DELISTED
CATALENT, INC.
CTLT
| $1.76M | ﹤0.01% |
31,445
+732
| +2% | +$39.6K |
|
779
TFI International
TFII
$12.1B
| $1.76M | ﹤0.01% |
11,157
+229
| +2% | +$32.8K |
|
|
MRO
780
DELISTED
Marathon Oil Corporation
MRO
| $1.76M | ﹤0.01% |
63,962
-7,918
| -11% | -$191K |
|
781
Omega Healthcare
OHI
$13.9B
| $1.76M | ﹤0.01% |
57,289
-20,016
| -26% | -$608K |
|
782
DaVita
DVA
$11.4B
| $1.76M | ﹤0.01% |
12,929
+1,501
| +13% | +$180K |
|
783
Kilroy Realty
KRC
$4.3B
| $1.75M | ﹤0.01% |
49,420
+5,749
| +13% | +$212K |
|
784
Acadia Pharmaceuticals
ACAD
$4.89B
| $1.75M | ﹤0.01% |
97,284
+2,731
| +3% | +$67.7K |
|
785
SK Telecom
SKM
$14.1B
| $1.74M | ﹤0.01% |
83,450
| – | – |
|
786
Arvinas
ARVN
$589M
| $1.74M | ﹤0.01% |
42,000
| – | – |
|
787
Jack Henry & Associates
JKHY
$11.1B
| $1.73M | ﹤0.01% |
10,116
+562
| +6% | +$95.7K |
|
788
Idacorp
IDA
$8.16B
| $1.73M | ﹤0.01% |
18,842
| – | – |
|
789
First Citizens BancShares
FCNCA
$25.6B
| $1.72M | ﹤0.01% |
1,081
-55
| -5% | -$82.7K |
|
790
Dyne Therapeutics
DYN
$4.85B
| $1.71M | ﹤0.01% |
60,000
+20,000
| +50% | +$452K |
|
791
Gold Fields
GFI
$35.4B
| $1.7M | ﹤0.01% |
110,000
-10,100
| -8% | -$140K |
|
792
Beam Therapeutics
BEAM
$2.74B
| $1.7M | ﹤0.01% |
50,000
| – | – |
|
793
Pan American Silver
PAAS
$19.9B
| $1.68M | ﹤0.01% |
115,192
-24,550
| -18% | -$339K |
|
794
NorthWestern Energy
NWE
$4.4B
| $1.67M | ﹤0.01% |
33,664
-6,019
| -15% | -$294K |
|
795
Xenon Pharmaceuticals
XENE
$6.21B
| $1.67M | ﹤0.01% |
39,000
| – | – |
|
796
Regenxbio
RGNX
$704M
| $1.64M | ﹤0.01% |
74,600
| – | – |
|
797
Teleflex
TFX
$5.82B
| $1.61M | ﹤0.01% |
7,290
+180
| +3% | +$42.8K |
|
798
ADMA Biologics
ADMA
$2.11B
| $1.59M | ﹤0.01% |
236,178
| – | – |
|
799
HEICO Corp Class A
HEI.A
$38.1B
| $1.58M | ﹤0.01% |
10,157
+4,541
| +81% | +$672K |
|
800
Revolution Medicines
RVMD
$43.3B
| $1.58M | ﹤0.01% |
50,000
| – | – |
|
Similar funds
NAMI
DekaBank Deutsche Girozentrale's Q1 2024 Portfolio in Review
As of Q1 2024, DekaBank Deutsche Girozentrale held 1,539 positions worth $53.7B, up 10% from $48.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
DekaBank Deutsche Girozentrale's Q1 2024 filing shows 66 new, 528 increased, 500 reduced and 103 closed positions. Its largest new stake was Flutter Entertainment: 112,763 shares worth $22.5M. The largest sale was XORTX Therapeutics, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q1 2024 buy was Flutter Entertainment: 112,763 shares worth $22.5M.
- DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q1 2024, an estimated $157M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2024 reduction was Voya Financial, cutting an estimated $99.6M.
- DekaBank Deutsche Girozentrale fully exited XORTX Therapeutics in Q1 2024, selling an estimated $161M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 27% of its $53.7B portfolio in Q1 2024.
- DekaBank Deutsche Girozentrale opened 66 new positions and closed 103 in Q1 2024.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $53.7B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.